Table 2. RAS mutation status and NOX1 mRNA expression in 28 colon cell lines from the ATCC.

Status	ATCC cell line	RAS mutation	NOX1/β-actin × 106	Origin	Corroboration in literature
	SW403	KRAS G12V	120303	Colorectal adenocarcinoma	[47–50]
	SW480	KRAS G12V	47	Colorectal adenocarcinoma	[47, 49–51]
	SW620	KRAS G12V	3	Colorectal adenocarcinoma	[47, 49–51]
	LS174T	KRAS G12D	96065	Colorectal adenocarcinoma	[49–51]
	LS123	KRAS G12S	144	Colorectal adenocarcinoma	[49]
	SW837	KRAS G12C	95	Colorectal adenocarcinoma	[47–50]
	DLD-1	KRAS G13D	8546	Colorectal adenocarcinoma	[50, 51]
	HCT-8	KRAS G13D	6748	Colorectal adenocarcinoma	[48]
	T84	KRAS G13D	1157	Colorectal carcinoma	[47–49]
	LoVo	KRAS G13D	219	Colorectal adenocarcinoma	[47–51]
	HCT-15	KRAS G13D	198	Colorectal adenocarcinoma	[47–51]
	HCT-116	KRAS G13D	118	Colorectal carcinoma	[47–51]
	SW948	KRAS Q61L	1437	Colorectal adenocarcinoma	[48–51]
HRAS mutant CRC	SW1116	HRAS G161R	494	Colorectal adenocarcinoma	KRAS G12A [48–51]
	SW48	HRAS G161R	7	Colorectal adenocarcinoma	KRAS WT [48–51]
RAS WT CRC	HT-29	RAS WT	33697	Colorectal adenocarcinoma	[48–51]
	WiDr	RAS WT	33513	Colorectal adenocarcinoma	[50, 51]
	Caco-2	RAS WT	16975	Colorectal adenocarcinoma	[48, 50, 51]
	COLO 201	RAS WT	10	Colorectal adenocarcinoma	[48]
	COLO 205	RAS WT	931	Colorectal adenocarcinoma	[48–50]
	COLO 320HSR	RAS WT	21	Colorectal adenocarcinoma	[49–51]
	COLO 320DM	RAS WT	40	Colorectal adenocarcinoma	[48, 50, 51]
	LS1034	RAS WT	45194	Colorectal carcinoma	KRAS A146T [49–51]
	SW1417	RAS WT	22	Colorectal adenocarcinoma	[48, 49]
	RKO	RAS WT	4	Colon carcinoma	[48–51]
	RKO-E6	RAS WT	1	Derived from RKO; disrupted p53 function	[48–51]
	p53R	RAS WT	1	Derived from RKO	[52]
RAS WT normal colon	CCD-18Co	RAS WT	85	Normal colon fibroblast	[53]

Mutations were identified by Sanger sequencing, and NOX1 mRNA level was measured by PCR and normalized to β-actin. CRC, colorectal cancer.